✦ LIBER ✦

A post-marketing safety and efficacy assessment of a monoclonal antibody purified high-purity factor VIII concentrate

✍ Scribed by C. R. M. HAY; C. A. LEE; G. SAVIDGE

Book ID: 108769337
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 424 KB
Volume: 2
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.1996.tb00007.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of high doses of a monoclonal ant

Safety of high doses of a monoclonal antibody-purified factor IX concentrate

✍ Dr. Indira Warrier; Carol K. Kasper; Gilbert C. White II; Amy D. Shapiro; Garret 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

Safety and efficacy of a plasma-derived

Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up

✍ E. P. MAUSER-BUNSCHOTEN; D. POSTHOUWER; K. FISCHER; H. M. VAN DEN BERG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

A clinical study assessing the pharmacok

A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAVILSKA; P. ŁAGUNA; L. GERCHEVA; A. ANTONOV; N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Clinical assessment of Optivate®, a high

Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Efficacy and safety of a high purity, do

Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate®) in patients with von Willebrand disorder requiring invasive or surgical procedures

✍ J. SHORTT; S. DUNKLEY; K. RICKARD; R. BAKER; A. STREET 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

An open clinical study assessing the eff

An open clinical study assessing the efficacy and safety of Factor IX Grifols®, a high-purity Factor IX concentrate, in patients with severe haemophilia B

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. MONTAÑES; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB